Skip to main content
. 2016 May 16;11:24. doi: 10.1186/s13027-016-0071-z

Table 2.

Wholesale acquisition cost of direct-acting antivirals

Direct-acting antiviral Pharmaceutical company WAC for 12 week course
Sofosbuvir (Sovaldi) Gilead sciences $84,000
Ledipasvir/Sofosbuvir (Harvoni) Gilead sciences $94,500
Ombitasvir/paritaprevir/ritonavir + Dasabuvir (Viekira Pak) AbbVie $83,319
Daclatasvir (Daklinza) + Sofosbuvir (Sovaldi) Bristol-Myers Squibb and Gilead $147,000
Grazoprevir/Elbasvir (Zepatier) Merck $54,600